Genistein modulates the decreased drug accumulation in non-p-glycoprotein mediated multidrug resistant tumour cells

British Journal of Cancer

Volumn 68, Issue 5, 1993, Pages 939-946

  Versantvoort, C H M ^a   Schuurhuis, G J ^a   Pinedo, H M ^a   Eekman, C A ^a   Kuiper, C M ^a   Lankelma, J ^a   Broxterman, H J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; BIOCHANIN A; DAUNORUBICIN; ETOPOSIDE; GENISTEIN; GLYCOPROTEIN P; QUERCETIN; TRANSFERASE INHIBITOR;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ALKALOIDS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE; ETOPOSIDE; GENISTEIN; HUMAN; HYDROGEN-ION CONCENTRATION; ISOFLAVONES; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; NEOPLASMS; P-GLYCOPROTEIN; PROTEIN-TYROSINE KINASE; STAUROSPORINE; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0027482403     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.458     Document Type: Article

References (48)

1. AKIYAMA, T., ISHIDA, J., NAKAGAWA, S., OGAWARA, H., WATANABE, S.-I., ITOH, N., SHIBUYA, M. & FUKAMI, Y. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592-5595.
2. BAAS, F., JONGSMA, A.P.M., BROXTERMAN, H.J., ARCECI, R.J., HOUSMAN, D., SCHEFFER, G.L., RIETHORST, A., VAN GROENIGEN, M., NIEUWINT, A.W.M. & JOENJE, H. (1990). Non-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res., 50, 5392-5398.
3. BARRAND, M.A., RHODES, T., CENTER, M.S. & TWENTYMAN, P R. (1993). Chemosensitisation and drug accumulation effects of cyclosporin A, PSC 833 and verapamil in human MDR large cell lung cancer cells expressing a 190 kD membrane protein distinct from P-glycoprotein. Eur. J. Cancer, 29A, 408-415.
4. BATES, S.E., CURRIER, S.J., ALVAREZ, M. & FOJO, AT. (1992). Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry, 31, 6366-6372.
5. BOURHIS, J., BENARD, J., HARTMANN, O., BOCCON-GIBOD, L., LEMERLE, J. & RIOU, G. (1989). Correlation of mdrl gene expression with chemotherapy in neuroblastoma. J. Natl Cancer Inst., 81, 11401-1405.
6. BROXTERMAN, H.J., KUIPER, C M., SCHUURHUIS, G.J., TSURUO, T., PINEDO, H.M. & LANKELMA, J. (1988). Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein. Biochem. Pharmacol., 37, 2389-2393.
7. BROXTERMAN, H.J. & PINEDO, H.M. (1991). Energy metabolism in multidrug resistant tumor cells: a review. J. Cell. Pharmacol., 2, 239-247.
8. CHAMBERS, T.C., ZHENG, B. & KUO, J.F. (1992). Regulation by phorbol ester and protein kinase C inhibitors, and by protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol. Pharmacol., 41, 1008-1015.
9. CHAN, H.S.L., THORNER, P.S., HADDAD, G. & LING, V. (1990). Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft-tissue sarcoma of childhood. J. Clin. Oncol., 8, 689-704.
10. COLE, S.P.C., DOWNES, H.F. & SLOVAK, M.L. (1989). Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. Br. J. Cancer, 59, 42-46.
11. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, M.V. & DEELEY, R.G. (1992). Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650-1654.
12. COLE, S.P.C. (1993). A novel ATP-binding cassette transporter gene overexpressed in multidrug-resistant human lung tumour cells. Proc. Am. Assoc. Cancer. Res., 34, 579.
13. COLEY, H.M., WORKMAN, P. & TWENTYMAN, P.R. (1991). Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. Br. J. Cancer, 63, 351-357.
14. DEAN, N.M., KANEMITSU, M. & BOYNTON, A.L. (1989). Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem. Biophys. Res. Commun., 165, 795-801.
15. DE JONG, S., ZIJLSTRA, J.G., DE VRIES, E.G.E. & MULDER, N.H. (1990). Reduced DNA topoisomerase II activity and drug-induced cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 50, 304-309.
16. DE LANGE, J.H.M., SCHIPPER, N.W., SCHUURHUIS, G.J., VAN HEIJNINGEN, T.H.M., PINEDO, H.M., LANKELMA, J. & BAAK, J.P.A. (1992). Quantification by laser scan microscopy of intracellular doxorubicin distribution. Cytometry, 13, 571-576.
17. ENDICOTT, J.A. & LING, V. (1989). The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58, 137-171.
18. FINE, R.L., PATEL, J. & CHABNER, B.A. (1988). Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl Acad. Sci, USA, 85, 582-586.
19. GERVASONI, J.E. Jr, FIELDS, S.Z., KRISHNA, S., BAKER, M.A., ROSADO, M., THURAISAMY, K., HINDENBURG, A.A. & TAUB, R.N. (1991). Subcellular distribution of daunorubicin in P-glycoprotein-positive and negative drug-resistant cells lines using laser-assisted confocal microscopy. Cancer Res., 51, 4955-4963.
20. HONMA, Y., OKABE-KADO, J., KASUKABE, T., HOZUMI, M., KODAMA, H., KAJIGAYA, S., SUDA, T. & MIURA, Y. (1992). Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia Cl cells with high expression of v-abl tyrosine kinase. Cancer Res., 52, 4017-4020.
21. KUIPER, C M., BROXTERMAN, H.J., BAAS, F., SCHUURHUIS, G.J., HAISMA, H.J., SCHEFFER, G.L., LANKELMA, J. & PINEDO, H.M. (1990). Drug transport variants without P-glycoprotein overexpression from a squamous-lung-cancer cell line after selection with doxorubicin. J. Cell. Pharmacol., 1, 35-41.
22. LAI, S.-L., GOLDSTEIN, L.J., GOTTESMAN, M.M., PASTAN, I., TSAI, C.M., JOHNSON, B E., MULSHINE, J.L., IHDE, D C., KAYSER, K. & GAZDAR, A.F. (1989). MDR1 gene expression in lung cancer. J. Natl Cancer Inst., 81, 1144-1150.
23. LINN, S.C., GIACCONE, G., VAN KALKEN, C.K. & PINEDO, H.M. (1992). P-glycoprotein mediated multidrug resistance and its clinical relevance in cancer treatment. Forum, 2, 642-657.
24. MA, L., MARQUARDT, D., TAKEMOTO, L. & CENTER, M.S. (1991). Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem., 266, 5593-5599.
25. MARKOVITS, J., LINASSIER, C., FOSSE, P., COUPRIE, J., PIERRE, J., JACQUEMIN-SABLON, A., SAUCIER, J. M., LE PECQ, J.-B. & LARSEN, A.K. (1989). Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 49, 5111-5117.
26. MARQUARDT, D., McCRONE, S. & CENTER, M.S. (1990). Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res., 50, 1426-1430.
27. MCGRATH, T., LATOUD, C., ARNOLD, S T., SAFA, A.R., FELSTED, L. & CENTER, M.S. (1989). Mechanisms of multidrug resistance in HL60 cells: analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem. Pharmacol., 38, 3611-3619.
28. NOONAN, K.E., BECK, C., HOLZMAYER, T.A., CHIN, J.E., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., van HOFF, D.D. & RONINSON, I.B. (1990). Quantitative analysis of mdr 1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl Acad. Sci, USA, 87, 7160-7164.
29. NOOTER, K., SONNEVELD, P., OOSTRUM, R., HERWEIJER, H., HAGENBEEK, T. & VALERIO, D. (1990). Overexpression of the mdrl gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int. J. Cancer, 45, 263-268.
30. SCHEPER, R.J., BROXTERMAN, H.J., SCHEFFER, G.L., KAAIJK, P., DALTON, W.S., VAN HEIJNINGEN, T.H.M., VAN KALKEN, C.K., SLOVAK, M L., DE VRIES, E.G.E., VAN DER VALK, P., MEIJER, J.L.M. & PINEDO, H.M. (1993). Overexpression of a Mr 110, 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479.
31. SCHUURHUIS, G.J., BROXTERMAN, H.J., CERVANTES, A., VAN HEIJNINGEN, T.H.M., DE LANGE, J.H.M., BAAK, J.P.A., PINEDO, H.M. & LANKELMA, J. (1989). Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells. J. Natl Cancer Inst., 81, 1887-1892.
32. SCHUURHUIS, G.J., PINEDO, H.M., BROXTERMAN, H.J., VAN KALKEN, C.K., KUIPER, C.M. & LANKELMA, J. (1990). Differential sensitivity of multi-drug-resistant and -sensitive cells to resistance-modifying agents and the relation with reversal of anthracycline resistance. Int. J. Cancer, 46, 330-336.
33. SCHUURHUIS, G.J., BROXTERMAN, H.J., DE LANGE, J.H.M., PINEDO, H.M., VAN HEIJNINGEN, T.H.M., KUIPER, C M., SCHEFFER, G.L., SCHEPER, R.J., VAN KALKEN, C.K., BAAK, J.P.A. & LANKELMA, J. (1991). Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br. J. Cancer, 64, 857-861.
34. SKOVSGAARD, T. & NISSEN, N.I. (1982). Membrane transport of anthracyclines. Pharmacol. Ther., 18, 293-311.
35. SLOVAK, M L., HOELTGE, G.A., DALTON, W.S. & TRENT, J.M. (1988). Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res., 48, 2793-2797.
36. SLOVAK, M L., HO, J., DEELEY, R.G. & COLE, S.P.C. (1993). Localization of a novel multidrug resistance associated gene on two non-P-glycoprotein mediated doxorubicin-selected cells. Proc. Am. Ass. Cancer Res., 34, 23.
37. TAKEDA, Y., NISHIO, K., SUGIMOTO, Y., KASAHARA, K., KUBO, S., FUJIWARA, Y., NIITANI, H. & SAIJO, N. (1991). Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-0-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance. Int. J. Cancer, 48, 931-937.
38. TAKEDA, Y., NISHIO, K., MORIKAGE, T., KUBOTA, N., KOJIMA, A., KUBO, S., FUJIWARA, Y., NIITANI, H. & SAIJO, N. (1992). Reversal of multidrug resistance by genistein in non-P-glycoprotein mediated multidrug-resistant cell line (K562/TPA). Proc. Amer. Ass. Cancer Res., 33, 476.
39. TAYLOR, C.W., DALTON, W.S., PARRISH, P R., GLEASON, M.C., BELLAMY, W.T., THOMPSON, F.H., ROE, D.J. & TRENT, J.M. (1991). Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br. J. Cancer, 63, 923-929.
40. VERSANTVOORT, C.H.M., BROXTERMAN, H.J., FELLER, N., DEKKER, H., KUIPER, C.M. & LANKELMA, J.C. (1992a). Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin. Int. J. Cancer, 50, 906-911.
41. VERSANTVOORT, C.H.M., BROXTERMAN, H.J., PINEDO, H.M., FELLER, N., KUIPER, C M. & LANKELMA, J. (1992b). Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res., 52, 17-23.
42. VERSANTVOORT, C.H.M., TWENTYMAN, PR., BARRAND, M.A., LANKELMA, J., PINEDO, H.M. & BROXTERMAN, H.J. (1992c). Overexpression of 110 and 190 kD proteins in cancer cells may be involved in drug resistant phenotype. Proc. Am. Assoc. Cancer Res., 33, 456.
43. YONEDA, T., LYALL, R.M., ALSINA, M.M., PERSONS, P.E., SPADA, A.P., LEVITZKI, A., ZILBERSTEIN, A. & MUNDY, G.R. (1991). The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res., 51, 4430-4435.
44. YU, G., AHMAD, S., AQUINO, A., FAIRCHILD, C.R., TREPEL, J.B., OHNO, S., SUZUKI, K., TSURUO, T., COWAN, K.H. & GLAZER, R.I. (1991). Transfection with protein kinase Ca confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun., 3, 181-189.
45. YUSA, K. & TSURUO, T. (1989). Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycroprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res., 49, 5002-5006.
46. QIAN, X.-D. & BECK, W.T. (1990). Binding of optically pure photaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant leukemic cell lines. Cancer Res., 50, 1132-1137.
47. ZAMAN, G.J.R., VERSANTVOORT, C.H.M., SMIT, J.J.M., EIJDEMS, E.W.H.M., DE HAAS, M., SMITH, A.J., BROXTERMAN, H.J., MULDER, N.H., DE VRIES, E.G.E, BAAS, F. & BORST, P. (1993). Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750.
48. ZIJLSTRA, J.G., DE VRIES, E.G.E. & MULDER, N.H. (1987). Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47, 1780-1784.